Signature Equity Partners’s RXO RXO Stock Holding History

Signature Equity Partners’s Portfolio RXO Stock Details RXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22	Closed	-$278	–	1636
2025 Q4	$278	Buy	+22	New	+$325	﹤0.01%	1604

Other funds holding RXO

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Signature Equity Partners's RXO Position: Q1 2026 in Review

Signature Equity Partners sold out of RXO (RXO) in Q1 2026, closing a stake of 22 shares — an estimated $278 sold.

Signature Equity Partners first reported a position in RXO in Q4 2025 and held it in 1 quarter. The position peaked at $278 in Q4 2025. 276 funds tracked by Wall St. Rank hold RXO as of Q1 2026.

Signature Equity Partners reported no remaining RXO position as of Q1 2026 after selling out during the quarter.
Signature Equity Partners sold 22 RXO shares in Q1 2026, an estimated $278.
Signature Equity Partners first reported a position in RXO in Q4 2025 and held it in 1 quarter.
Signature Equity Partners's RXO position peaked at $278 in Q4 2025.
276 funds tracked by Wall St. Rank held RXO as of Q1 2026.

Based on Signature Equity Partners's 13F filing for Q1 2026, filed 13 May 2026.